Synthesis, stereochemical identification, and selective inhibitory activity against human monoamine oxidase-B of 2-methylcyclohexylidene-(4-arylthiazol-2-yl)hydrazones

被引：92

作者：

Chimenti, Franco ^{[1
]}

Maccioni, Elias ^{[2
]}

Secci, Daniela ^{[1
]}

Bolasco, Adriana ^{[1
]}

Chimenti, Paola ^{[1
]}

Granese, Arianna ^{[1
]}

Carradori, Simone ^{[1
]}

Alcaro, Stefano ^{[3
]}

Ortuso, Francesco ^{[3
]}

Yanez, Matilde ^{[4
]}

Orallo, Francisco ^{[4
]}

Cirilli, Roberto ^{[5
]}

Ferretti, Rosella ^{[5
]}

La Torre, Francesco ^{[5
]}

机构：

[1] Univ Roma La Sapienza, Dipartimento Chim & Tecnol Sostanze Biol Camente, I-00185 Rome, Italy

[2] Univ Cagliari, Dipartimento Farmaco Chim Tecnol, I-09124 Cagliari, Italy

[3] Univ Catanzaro Magna Graecia, Dipartimento Sci Farmaco Biol Complesso Nini Barb, I-88021 Roccelletta Di Borgia, CZ, Italy

[4] Univ Santiago Compostela, Fac Farm, Dept Farmacol, E-15782 La Coruna, Spain

[5] Ist Super Sanita, Dipartimento Farmaco, I-00161 Rome, Italy

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2008年 / 51卷 / 16期

关键词：

D O I：

10.1021/jm800132g

中图分类号：

R914 [药物化学];

学科分类号：

100701 [药物化学];

摘要：

A series of 2-methylcyclohexylidene-(4-arylthiazol-2-yl)hydrazones have been investigated for their ability to inhibit selectively the activity of the human A and B isoforms of monoamine oxidase (MAO). The target compounds, which present a stereogenic center on the cyclohexane ring, were obtained as pure (R) and (S) enantiomers by enantioselective HPLC. The absolute configuration of homochiral forms isolated on a semipreparative scale was obtained by a combined strategy based on chemical correlation and single-crystal X-ray diffraction. All compounds showed higher activity against the human MAO-B isoform with IC(50) values ranging between 26.81 +/- 2.74 mu M and 14.20 +/- 0.26 nM, and the assays carried out on the pure enantiomers showed higher activity for the (R) form. A computational study was performed by molecular mechanics, DFT-based quantomechanics, and docking techniques on the most active and human MAO-B selective inhibitor 8.

引用

页码：4874 / 4880

页数：7

共 35 条

[1]

Quasi flexible automatic docking processing for studying stereoselective recognition mechanisms, part 2:: Prediction of ΔΔG of complexation and 1H-NMR NOE correlation [J].

Alcaro, S. ;

Gasparrini, F. ;

Incani, O. ;

Caglioti, L. ;

Pierini, M. ;

Villani, C. .

JOURNAL OF COMPUTATIONAL CHEMISTRY, 2007, 28 (06) :1119-1128

[2]

The Protein Data Bank [J].

Berman, HM ;

Westbrook, J ;

Feng, Z ;

Gilliland, G ;

Bhat, TN ;

Weissig, H ;

Shindyalov, IN ;

Bourne, PE .

NUCLEIC ACIDS RESEARCH, 2000, 28 (01) :235-242

[3]

Structure-function relationships in flavoenzyme-dependent amine oxidations. A comparison of polyamine oxidase and monoamine oxidase. [J].

Binda, C ;

Mattevi, A ;

Edmondson, DE .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (27) :23973-23976

[4]

Structure of human monoamine oxidase B, a drug target for the treatment of neurological disorders [J].

Binda, C ;

Newton-Vinson, P ;

Hubálek, F ;

Edmondson, DE ;

Mattevi, A .

NATURE STRUCTURAL BIOLOGY, 2002, 9 (01) :22-26

[5]

Crystal structure of human monoamine oxidase B, a drug target enzyme monotopically inserted into the mitochondrial outer membrane [J].

Binda, C ;

Hubálek, F ;

Li, M ;

Edmondson, DE ;

Mattevi, A .

FEBS LETTERS, 2004, 564 (03) :225-228

[6]

Carreiras MC, 2004, CURR PHARM DESIGN, V10, P3167

[7]

Therapeutic potential in Alzheimer disease [J].

Cash, AD ;

Perry, G ;

Smith, MA .

CURRENT MEDICINAL CHEMISTRY, 2002, 9 (17) :1605-1610

[8]

Synthesis and molecular modelling of novel substituted-4,5-dihydro-(1H)-pyrazole derivatives as potent and highly selective monoamine oxidase-A inhibitors [J].

Chimenti, F ;

Bolasco, A ;

Manna, F ;

Secci, D ;

Chimenti, P ;

Granese, A ;

Befani, O ;

Turini, P ;

Alcaro, S ;

Ortuso, F .

CHEMICAL BIOLOGY & DRUG DESIGN, 2006, 67 (03) :206-214

[9]

Synthesis, biological evaluation and 3D-QSAR of 1,3,5-trisubstituted-4,5-dihydro-(1H)-pyrazole derivatives as potent and highly selective monoamine oxidase a inhibitors [J].

Chimenti, F ;

Bolasco, A ;

Manna, F ;

Secci, D ;

Chimenti, P ;

Granese, A ;

Befani, O ;

Turini, P ;

Cirilli, R ;

La Torre, F ;

Alcaro, S ;

Ortuso, F ;

Langer, T .

CURRENT MEDICINAL CHEMISTRY, 2006, 13 (12) :1411-1428

[10]

Synthesis, molecular modeling studies, and selective inhibitory activity against monoamine oxidase of 1-thiocarbamoyl-3,5-diaryl-4,5-dihydro-(1H)-pyrazole derivatives [J].

Chimenti, F ;

Maccioni, E ;

Secci, D ;

Bolasco, A ;

Chimenti, P ;

Granese, A ;

Befani, O ;

Turini, P ;

Alcaro, S ;

Ortuso, F ;

Cirilli, R ;

La Torre, F ;

Cardia, MC ;

Distinto, S .

JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (23) :7113-7122

← 1 2 3 4 →